• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data

by Fred Pennic 05/29/2024 Leave a Comment

Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data

What You Should Know:  - Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to streamline patient participation and enhance data collection for clinical trials. - By offering a patient-centric approach and fostering richer data collection, this collaboration holds promise for faster drug development, improved patient
Read More

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

by Fred Pennic 05/21/2024 Leave a Comment

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

What You Should Know:  - Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration.  The first-of-its-kind partnership in the pharma and life sciences industries aims to leverage AI to accelerate drug development and bring new medicines to patients faster. - Sanofi, Formation Bio, and OpenAI believe this collaboration will be
Read More

Enable Injections & Serina Partner to Develop Novel Parkinson’s Treatment

by Syed Hamza Sohail 05/17/2024 Leave a Comment

Enable Injections & Serina Partner to Develop Novel Parkinson's Treatment

What You Should Know: -       Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform and Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its POZ Platform™ to develop and improve efficacy and safety across multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug
Read More

Trinity Biotech & PulseAI Partner for Smarter CGM with AI-Powered Analytics

by Syed Hamza Sohail 05/17/2024 Leave a Comment

Trinity Biotech & PulseAI Partner for Smarter CGM with AI-Powered Analytics

What You Should Know: -       Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology. -       Under this collaboration,
Read More

Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery

by Fred Pennic 05/16/2024 Leave a Comment

Accenture Backs Turbine's AI-Powered Platform to Accelerate Drug Discovery

What You Should Know:  - Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.  - The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes. Optimizing Drug Discovery with Simulated
Read More

Brixton Biosciences Secures $33M to Advance Novel Pain Therapies

by Fred Pennic 05/14/2024 Leave a Comment

Brixton Biosciences Secures $33M to Advance Novel Pain Therapies

What You Should Know:  - Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with participation from  SV Health Investors, Sparta Group, Excelestar Ventures,  PV Capital Management, and Catalyst Health Ventures. - In addition, Brixton has bolstered its leadership team. Dr. Michael Fishman, a renowned pain management specialist, joins as Chief Medical Officer. Additionally,
Read More

Flatiron & ACCC Partner to Expand Community Oncology Clinical Trials

by Jasmine Pennic 05/13/2024 Leave a Comment

Flatiron & ACCC Partner to Expand Community Oncology Clinical Trials

What You Should Know:  - Flatiron Health, an oncology-focused healthtech company, and the Association of Cancer Care Centers (ACCC), a powerful network of cancer care professionals, are proud to announce a new collaboration.  - The partnership aims to make cancer clinical trials more accessible to patients in community settings and empower healthcare providers with cutting-edge data capture technology. Boosting Clinical Trial Participation ACCC boasts over 40,000 members
Read More

Enable Injections, Roche Expand Partnership to Advance Wearable Drug Delivery

by Fred Pennic 05/08/2024 Leave a Comment

Enable Injections, Roche Expand Partnership to Advance Wearable Drug Delivery

- Enable Injections, Inc. ("Enable"), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche.  - The collaboration leverages Enable's expertise in the enFuse® platform to accelerate the development and commercialization of innovative treatment options. EnFuse Technology: Revolutionizing Drug Delivery The enFuse platform is a groundbreaking wearable device designed for: Subcutaneous Delivery of Large Volumes: Unlike traditional methods,
Read More

BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

by Jasmine Pennic 05/08/2024 Leave a Comment

BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

What You Should Know;  - Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., a dedicated subsidiary focused on developing and commercializing innovative BioChips – advanced microfluidic platforms that mimic human organs.  - By leveraging BioChip technology, BMF Biotechnology aims to accelerate breakthroughs in drug development, improve cosmetic safety and efficacy testing, and ultimately, contribute to the development of more effective treatments
Read More

ARTBIO, Nucleus RadioPharma Partner to Advance Targeted Alpha Radioligand Therapies for Cancer

by Jasmine Pennic 05/07/2024 Leave a Comment

ARTBIO and Nucleus RadioPharma Join Forces to Advance Targeted Alpha Radioligand Therapies for Cancer

What You Should Know:  - ARTBIO, Inc., a leader in developing targeted alpha radioligand therapies (ARTs) for cancer, and Nucleus RadioPharma Inc., a pioneer in radiopharmaceutical development and manufacturing, announced today a strategic collaboration to propel ARTBIO's clinical trials forward. Nucleus to Manufacture ARTBIO's Lead Therapy Candidate This agreement signifies a significant step for ARTBIO. Nucleus will manufacture ARTBIO's 212Pb-radiolabeled therapies for its
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 22
  • Go to page 23
  • Go to page 24
  • Go to page 25
  • Go to page 26
  • Interim pages omitted …
  • Go to page 87
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |